Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04484896
Other study ID # Recruiting Rh-D- blood donors
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 22, 2020
Est. completion date July 30, 2020

Study information

Verified date July 2020
Source Guangzhou Blood Center
Contact Jian OU-YANG
Phone +8615918771924
Email 434524249@qq.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Rh negative blood group is a rare blood group in China, as it only accounts for 0.3-0.4 percent of the Han population. Therefore, low inventory is often found in blood collection and supply agencies in many regions in China. On July 22, 2020 blood stockpile of O-negative and A-negative in Guangzhou Blood Center reached the warning line, and we took measures for emergency recruitment. O-negative and A-negative blood donors whose last donation dates were between January 1, 2018 and December 31, 2019 were identified and randomly assigned to four groups. Three different recruitment text messages were send three groups. We observed the re-donation rates among four groups within one week.


Recruitment information / eligibility

Status Recruiting
Enrollment 1082
Est. completion date July 30, 2020
Est. primary completion date July 29, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- O and A Rh- negative blood donors Last donations were between January 1, 2018 and December 31, 2019

Exclusion Criteria:

- With an obviously invalid phone number Serological results of the last donation were positive

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Gain-framed SMS message
Emergency recruitment cell phone short messages that emphasizing donating blood can save patients' lives were sent to donors in this group.
Loss-framed SMS message
Emergency recruitment cell phone short messages emphasizing that donating blood can prevent patients from death were sent to donors in this group.
Information SMS message
Emergency recruitment cell phone short messages that only mentioning the low Rh-negative blood stockpile were sent to donors in this group.

Locations

Country Name City State
China Guangzhou Blood Center Guangzhou Guangdong

Sponsors (1)

Lead Sponsor Collaborator
Guangzhou Blood Center

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Re-donation rate Intention-to-treat were applied. Re-donation rate was defined as the number of donors in each group divided by donors who re-donated within 7 days. 7 days
See also
  Status Clinical Trial Phase
Recruiting NCT05791968 - Blood Donation Could Improve Insulin Sensitivity N/A
Recruiting NCT02281565 - Attitudes About Blood Donation N/A
Recruiting NCT06101238 - BLOODSAFE Ghana- Iron and Nutritional Counselling Strategy N/A
Enrolling by invitation NCT04410458 - Recruit Blood Donors Via SMS During Epidemic of COVID-19 (Repeat Trial) N/A
Completed NCT04306055 - Blood Donor Recruitment During Epidemic of COVID-19 N/A
Active, not recruiting NCT01610635 - INTERVAL Study: To Determine Whether the Interval Between Blood Donations in England Can be Safely and Acceptably Decreased N/A
Enrolling by invitation NCT04431180 - Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial# N/A
Active, not recruiting NCT05678647 - Sucrosomial Iron and Iron Sulphate to Blood Donors N/A
Completed NCT05319951 - Effect of Different Liquids Intake in Vasovagal Reaction After Whole Blood Donation N/A
Completed NCT05213130 - Blood Donation and Subjective Well-being N/A
Completed NCT00023023 - Study of Transfusion-Transmitted Infections
Enrolling by invitation NCT06138899 - Enhancing Blood Donation at Schools and Beyond in Malawi N/A
Completed NCT04370886 - Recruit Blood Donors Via SMS During Epidemic of COVID-19 N/A